Prevalence of statin intolerance: a meta-analysis

I Bytyci, PE Penson, DP Mikhailidis… - European heart …, 2022 - academic.oup.com
Aims Statin intolerance (SI) represents a significant public health problem for which precise
estimates of prevalence are needed. Statin intolerance remains an important clinical …

[HTML][HTML] 2021 clinical practice guidelines for diabetes mellitus in Korea

KY Hur, MK Moon, JS Park, SK Kim… - Diabetes & …, 2021 - synapse.koreamed.org
Abstract The Committee of Clinical Practice Guidelines of the Korean Diabetes Association
(KDA) updated the previous clinical practice guidelines for Korean adults with diabetes and …

Association between immune checkpoint inhibitors with cardiovascular events and atherosclerotic plaque

ZD Drobni, RM Alvi, J Taron, A Zafar, SP Murphy… - Circulation, 2020 - Am Heart Assoc
Background: Immune checkpoint inhibitors (ICIs) treat an expanding range of cancers.
Consistent basic data suggest that these same checkpoints are critical negative regulators of …

Macrophages in atherosclerosis regression

TJ Barrett - Arteriosclerosis, thrombosis, and vascular biology, 2020 - Am Heart Assoc
Macrophages play a central role in the development of atherosclerotic cardiovascular
disease (ASCVD), which encompasses coronary artery disease, peripheral artery disease …

Pleiotropic effects of statins on the cardiovascular system

A Oesterle, U Laufs, JK Liao - Circulation research, 2017 - Am Heart Assoc
The statins have been used for 30 years to prevent coronary artery disease and stroke. Their
primary mechanism of action is the lowering of serum cholesterol through inhibiting hepatic …

Hydrophilic or lipophilic statins?

E Climent, D Benaiges, J Pedro-Botet - Frontiers in cardiovascular …, 2021 - frontiersin.org
Drugs can be classified as hydrophilic or lipophilic depending on their ability to dissolve in
water or in lipid-containing media. The predominantly lipophilic statins (simvastatin …

Effect of evolocumab on progression of coronary disease in statin-treated patients: the GLAGOV randomized clinical trial

SJ Nicholls, R Puri, T Anderson, CM Ballantyne, L Cho… - Jama, 2016 - jamanetwork.com
Importance Reducing levels of low-density lipoprotein cholesterol (LDL-C) with intensive
statin therapy reduces progression of coronary atherosclerosis in proportion to achieved …

Coronary Atherosclerotic Plaque Regression: JACC State-of-the-Art Review

LP Dawson, M Lum, N Nerleker, SJ Nicholls… - Journal of the American …, 2022 - jacc.org
Over the last 3 decades there have been substantial improvements in treatments aimed at
reducing cardiovascular (CV) events. As these treatments have been developed, there have …

Standards of medical care in diabetes—2014

American Diabetes Association - Diabetes care, 2014 - Am Diabetes Assoc
Diabetes mellitus is a complex, chronic illness requiring continuous medical care with
multifactorial risk reduction strategies beyond glycemic control. Ongoing patient self …

Impact of statins on serial coronary calcification during atheroma progression and regression

R Puri, SJ Nicholls, M Shao, Y Kataoka, K Uno… - Journal of the American …, 2015 - jacc.org
Background: Statins can regress coronary atheroma and lower clinical events. Although pre-
clinical studies suggest procalcific effects of statins in vitro, it remains unclear if statins can …